i
Sickle cell trait and diabetes tests : what every healthcare provider should know
-
8/26/15
-
Series: Sickle cell trait toolkit
Details:
-
Corporate Authors:
-
Description:According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the hemoglobin A1C assay may be unreliable for diagnosing and monitoring diabetes and prediabetes in individuals with sickle cell trait (SCT) or other hemoglobinopathies. In order to provide the best possible care for your patients, it is important to determine their SCT status and know whether the A1C test you normally use should be replaced or supplemented with a different test.
CS258998A
Publication date from document properties.
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: